RESEARCH PEPTIDE
TIRZEPATIDE
20mg
DUAL GIP & GLP-1 RECEPTOR AGONIST
Tirzepatide is a dual-receptor agonist that targets GIP and GLP-1 receptors. Extensively studied for its role in metabolic regulation, glucose homeostasis, appetite signaling, and body weight research, it represents an important advancement in incretin-based metabolic investigations.
View Research Information Center
MECHANISM OF ACTION
How Tirzepatide Works
Tirzepatide selectively activates both GIP and GLP-1 receptors, influencing multiple pathways involved in glucose regulation, insulin signaling, appetite, and energy metabolism.
Supports glucose-dependent insulin signaling and metabolic regulation.
Influences insulin secretion, glucagon regulation, and appetite signaling.
Studied for its effects on fasting and postprandial glucose regulation.
Investigated for its role in food intake and satiety signaling.
Enhances glucose-dependent first- and second-phase insulin secretion.
Combines GIP and GLP-1 receptor activity within metabolic pathways.
Research Applications
POTENTIAL BENEFITS
Key Benefits in Research Studies
Studied for its role in body weight regulation.
Investigated for effects on food intake and satiety.
Studied across multiple metabolic parameters.
Supports glucose regulation in research models.
Supports glucose-dependent insulin signaling.
Targets dual incretin pathways involved in metabolic regulation.
Technical Specifications
- Peptide
- Tirzepatide
- Appearance
- White Lyophilized Powder
- Purity
- ≥99%
- Molecular Formula
- C225H348N48O68
- Molecular Weight
- ~4,813.53 g/mol
- Storage (Lyophilized Powder)
- -20°C
- Storage After Reconstituted
- 2 °C TO 8°C
- Shelf Life
- 36 Months
- Grade
- Research Grade
- Application
- Laboratory Research
Quality Assurance
Manufactured under strict laboratory standards with purity verification and batch-controlled quality protocols.